Skip to main content
. 2017 May 19;2017(5):CD011598. doi: 10.1002/14651858.CD011598.pub2

28.6. Analysis.

28.6

Comparison 28 Parenteral ‐ Serious adverse event maximum follow‐up, Outcome 6 Serious adverse events ‐ participants characterised as 'at nutritional risk' due to one of the following conditions.